# Siemens and Akesobio sign automation contract for biopharma park

Siemens signed a commercial contract and technical agreement with Akeso Sano Pharma (Akesobio subsidiary) to provide automation and digitalization solutions for the Akesobio Bay Area Science and Technology Park, which includes a 40,000L stainless steel monoclonal antibody production line.

- Type: Contract
- Announced: 2022-02-24
- Where: Akesobio Bay Area Science and Technology Park, China
- Status: announced
- Capacity: 40,000L stainless steel process equipment
- Products: process automation systems, DCS, Batch, MCC, digitalization solutions
- Sectors: [Automation and Robotics](https://endata.com/sectors/automation-robotics.md), [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Siemens](https://endata.com/companies/301.md) (supplier)
- [Akesobio](https://endata.com/companies/61256.md) (customer)
- [Akeso Sano Pharma](https://endata.com/companies/61257.md) (customer)

## Sources

- [w1.siemens.com.cn](https://w1.siemens.com.cn/press/NewsDetail_en.aspx?ArticleId=17551&ColumnId=9), 2022-02-24: "Siemens will provide fully integrated automation portfolios including DCS, Batch and MCC, as well as the whole integrated digitalization solution from planning and design to implementation, laying a solid foundation for the future intelligent factory."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.